Tag:

Chip Clark

Latest Headlines

Latest Headlines

Genocea's HSV-2 vax to hit the clinic

June 20, 2012 | By
There is no preventive vaccine or cure, but Genocea Biosciences has a prophylactic HSV-2 vaccine moving into a first in-human clinical trial in third quarter 2012, Chip Clark, president and CEO told FierceVaccines at BIO 2012. Seth Hetherington, CMO, was also at the meeting, presenting in the session "Therapeutic Vaccines Against Chronic Infectious Diseases: Vaccines versus Microbes Part 2."
Related Tags
Press Releases
  • U.S. FDA Panel Supports Medtronic, Inc. (MDT) Pacemaker
  • Atritech, Inc. Announces FDA Regulatory Update; Confirmatory Study Required for Final FDA Approval
  • FDA APPROVES FIRST OF ITS KIND, FULLY IMPLANTABLE (SURGICALLY), INVISIBLE, PROSTHETIC HEARING RESTORATION DEVICE
  • CryoLife Comments on Status of Medafor Distribution Agreement
  • FDA Statement on Boston Scientific Recall of Implantable Cardioverter Defibrillators
  • More Press Releases
Featured Jobs
  • Medical Affairs Manager
    Lexicon Pharmaceuticals - The Woodlands, TX Princeton, NJ
  • Director, Clinical Process & Standards
    Infinity Pharmaceuticals - Cambridge, MA
  • Sr Manager, Marketing Research
    Allergan - Irvine, CA
  • Business Development Director - Mid-Atlantic Region, USA
    SynteracHCR -
  • Vice President, Global Medical Affairs - Breast Disease Lead Job
    Celgene Corporation - Summit NJ US
Sponsored Links